Moreover, gliomas with mutated IDH status and those with 1p/19q codeletion are associated with higher SHANK2 expression, suggesting a potential link between SHANK2 and these genetic alterations (Figures 1(e) and 1(f)). Here, IDH1 is linked to central nervous system cancer.